Art

J-GLOBAL ID：201902280187294090   Reference number：19A0980796

Generation of a human induced pluripotent stem cell line, BRCi001-A, derived from a patient with mucopolysaccharidosis type I

ムコ多糖症I型患者由来のヒト誘導多能性幹細胞株,BRCI001-Aの生成【JST・京大機械翻訳】

Author (20)： Suga Mika (iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center, Kyoto, Japan) ,  Suga Mika (Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan) ,  Kondo Takayuki (iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center, Kyoto, Japan) ,  Kondo Takayuki (Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan) ,  Imamura Keiko (iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center, Kyoto, Japan) ,  Imamura Keiko (Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan) ,  Shibukawa Ran (iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center, Kyoto, Japan) ,  Okanishi Yasue (iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center, Kyoto, Japan) ,  Sagara Yukako (iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center, Kyoto, Japan) ,  Tsukita Kayoko (iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center, Kyoto, Japan) ,  Tsukita Kayoko (Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan) ,  Enami Takako (Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan) ,  Furujo Mahoko (Department of Pediatrics, Okayama Medical Center, National Hospital Organization, Okayama, Japan) ,  Saijo Kaoru (Cell Engineering Division, RIKEN BioResource Research Center, Tsukuba, Japan) ,  Nakamura Yukio (Cell Engineering Division, RIKEN BioResource Research Center, Tsukuba, Japan) ,  Osawa Mitsujiro (Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan) ,  Saito Megumu K. (Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan) ,  Yamanaka Shinya (Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan) ,  Inoue Haruhisa (iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center, Kyoto, Japan) ,  Inoue Haruhisa (Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan)
Material： Stem Cell Research (Web)  (Stem Cell Res (Web))
Volume： 36  Page： ROMBUNNO.2019.101406  Publication year： 2019 
JST Material Number： U7041A  ISSN： 1873-5061  Document type： Article
Article type： 短報  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： Mucopolysaccharidosis type I (...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0980796&from=J-GLOBAL&jstjournalNo=U7041A") }}

Thesaurus term： Heredity ,  *pluripotent stem cell ,  Mutation ,  *human ,  lysosome ,  Proteins ,  gene ,  metabolic error ,  attenuation ,  Cognition Disorders ,  Genetic Variation
Semi thesaurus term： genetic variation ,  重症度 ,  全身性疾患 ,  *ムコ多糖症1型 , 【Automatic Indexing@JST】

JST classification (2)： Development(=generation)and differentiation  (EJ16020W) ,  Cell physiology in general  (EF02010S)

Terms in the title (6)： ムコ多糖症I型 ,  患者 ,  ヒト ,  誘導 ,  多能性幹細胞 ,  株